MycoBiomDB – Record Details (MyCo_2146)

Biomarker Record Details

Database ID: MyCo_2146
DB IDMyCo_2146
TitlePlasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia
Year2016
PMID27579328
Fungal Diseases involvedPneumocystis pneumonia
Associated Medical ConditionAIDS
GenusPneumocystis
Speciesspp.
OrganismPneumocystis spp.
Ethical StatementThe study was conducted in accordance with the 1975 Declaration of Helsinki and approved by the Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University, China.
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourcePlasma
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIL-6
Biomarker Full NameInterleukin-6
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationChina
CohortA total of 32 consecutive patients (>18 years of age) diagnosed with AIDS PCP at infectious department of the First Affiliated Hospital of Zhejiang University were enrolled from March 2013 to July 2014. HIV infection was confirmed as recommended by Center for Disease Control and Prevention (CDC).
Cohort No.32
Age Group>18
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismPneumocystispneumonia (PCP)is one of the most common opportunistic infections in HIV-infected patients with a sub-stantial mortality rate. A recent cohort study in China by Xiao et al. found that the top three most common opportunistic infections (OI) of hospitalized HIV-infected patients were tuberculosis (32.5%), candidiasis (29.3%), and PCP (2.4%), with PCP resulting in an in-hospital mortality rate of 33.1%. The incidence of PCP has declined with combination of antiretroviral therapy (ART) and PCPprophylaxis.Neverthe- less,PCPmayoccurinpatientswhoareunawareoftheirHIVinfection,areunabletoreachmedicalcare,orfailtoadhereto PCP prophylaxisorART. PCPcanalsoprogressrapidly into respiratory failure in patients not immediately treated with appropriate therapy. Early diagnosis of PCP in AIDS patientscanbechallenging,especiallywhentheCD4countis unknown; therefore, empiric therapy is often initiated based upon nonspecific clinical manifestations while awaiting the resultsofdiagnostictests.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsNone
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone